Market Segmentation
Report Scope
The Tacrolimus market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tacrolimus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tacrolimus manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tacrolimus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Tacrolimus Market Overview
1.1 Product Overview and Scope of Tacrolimus
1.2 Tacrolimus Segment by Type
1.2.1 Global Tacrolimus Market Value Comparison by Type (2024-2030)
1.2.2 Tacrolimus Capsules
1.2.3 Tacrolimus Ointment
1.2.4 Tacrolimus Injection
1.3 Tacrolimus Segment by Application
1.3.1 Global Tacrolimus Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Tacrolimus Market Size Estimates and Forecasts
1.4.1 Global Tacrolimus Revenue 2019-2030
1.4.2 Global Tacrolimus Sales 2019-2030
1.4.3 Global Tacrolimus Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tacrolimus Market Competition by Manufacturers
2.1 Global Tacrolimus Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tacrolimus Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tacrolimus Average Price by Manufacturers (2019-2024)
2.4 Global Tacrolimus Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tacrolimus, Product Type & Application
2.7 Tacrolimus Market Competitive Situation and Trends
2.7.1 Tacrolimus Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tacrolimus Players Market Share by Revenue
2.7.3 Global Tacrolimus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tacrolimus Retrospective Market Scenario by Region
3.1 Global Tacrolimus Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tacrolimus Global Tacrolimus Sales by Region: 2019-2030
3.2.1 Global Tacrolimus Sales by Region: 2019-2024
3.2.2 Global Tacrolimus Sales by Region: 2025-2030
3.3 Global Tacrolimus Global Tacrolimus Revenue by Region: 2019-2030
3.3.1 Global Tacrolimus Revenue by Region: 2019-2024
3.3.2 Global Tacrolimus Revenue by Region: 2025-2030
3.4 North America Tacrolimus Market Facts & Figures by Country
3.4.1 North America Tacrolimus Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tacrolimus Sales by Country (2019-2030)
3.4.3 North America Tacrolimus Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tacrolimus Market Facts & Figures by Country
3.5.1 Europe Tacrolimus Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tacrolimus Sales by Country (2019-2030)
3.5.3 Europe Tacrolimus Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tacrolimus Market Facts & Figures by Country
3.6.1 Asia Pacific Tacrolimus Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tacrolimus Sales by Country (2019-2030)
3.6.3 Asia Pacific Tacrolimus Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tacrolimus Market Facts & Figures by Country
3.7.1 Latin America Tacrolimus Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tacrolimus Sales by Country (2019-2030)
3.7.3 Latin America Tacrolimus Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tacrolimus Market Facts & Figures by Country
3.8.1 Middle East and Africa Tacrolimus Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tacrolimus Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tacrolimus Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tacrolimus Sales by Type (2019-2030)
4.1.1 Global Tacrolimus Sales by Type (2019-2024)
4.1.2 Global Tacrolimus Sales by Type (2025-2030)
4.1.3 Global Tacrolimus Sales Market Share by Type (2019-2030)
4.2 Global Tacrolimus Revenue by Type (2019-2030)
4.2.1 Global Tacrolimus Revenue by Type (2019-2024)
4.2.2 Global Tacrolimus Revenue by Type (2025-2030)
4.2.3 Global Tacrolimus Revenue Market Share by Type (2019-2030)
4.3 Global Tacrolimus Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tacrolimus Sales by Application (2019-2030)
5.1.1 Global Tacrolimus Sales by Application (2019-2024)
5.1.2 Global Tacrolimus Sales by Application (2025-2030)
5.1.3 Global Tacrolimus Sales Market Share by Application (2019-2030)
5.2 Global Tacrolimus Revenue by Application (2019-2030)
5.2.1 Global Tacrolimus Revenue by Application (2019-2024)
5.2.2 Global Tacrolimus Revenue by Application (2025-2030)
5.2.3 Global Tacrolimus Revenue Market Share by Application (2019-2030)
5.3 Global Tacrolimus Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Tacrolimus Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Tacrolimus Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Roche Pharma
6.3.1 Roche Pharma Corporation Information
6.3.2 Roche Pharma Description and Business Overview
6.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Pharma Tacrolimus Product Portfolio
6.3.5 Roche Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Tacrolimus Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Tacrolimus Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Corporation Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Squibb Tacrolimus Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Astellas
6.6.1 Astellas Corporation Information
6.6.2 Astellas Description and Business Overview
6.6.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Tacrolimus Product Portfolio
6.7.5 Astellas Recent Developments/Updates
6.8 Aarti Group
6.8.1 Aarti Group Corporation Information
6.8.2 Aarti Group Description and Business Overview
6.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aarti Group Tacrolimus Product Portfolio
6.8.5 Aarti Group Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Corporation Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Takeda Tacrolimus Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Huapont Pharma
6.10.1 Huapont Pharma Corporation Information
6.10.2 Huapont Pharma Description and Business Overview
6.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Huapont Pharma Tacrolimus Product Portfolio
6.10.5 Huapont Pharma Recent Developments/Updates
6.11 Senju Pharmaceutical
6.11.1 Senju Pharmaceutical Corporation Information
6.11.2 Senju Pharmaceutical Tacrolimus Description and Business Overview
6.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Senju Pharmaceutical Tacrolimus Product Portfolio
6.11.5 Senju Pharmaceutical Recent Developments/Updates
6.12 Guike Pharmaceutical
6.12.1 Guike Pharmaceutical Corporation Information
6.12.2 Guike Pharmaceutical Tacrolimus Description and Business Overview
6.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Guike Pharmaceutical Tacrolimus Product Portfolio
6.12.5 Guike Pharmaceutical Recent Developments/Updates
6.13 Tecoland
6.13.1 Tecoland Corporation Information
6.13.2 Tecoland Tacrolimus Description and Business Overview
6.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Tecoland Tacrolimus Product Portfolio
6.13.5 Tecoland Recent Developments/Updates
6.14 Sandoz
6.14.1 Sandoz Corporation Information
6.14.2 Sandoz Tacrolimus Description and Business Overview
6.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sandoz Tacrolimus Product Portfolio
6.14.5 Sandoz Recent Developments/Updates
6.15 ScinoPharm
6.15.1 ScinoPharm Corporation Information
6.15.2 ScinoPharm Tacrolimus Description and Business Overview
6.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ScinoPharm Tacrolimus Product Portfolio
6.15.5 ScinoPharm Recent Developments/Updates
6.16 RPG Life Science
6.16.1 RPG Life Science Corporation Information
6.16.2 RPG Life Science Tacrolimus Description and Business Overview
6.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.16.4 RPG Life Science Tacrolimus Product Portfolio
6.16.5 RPG Life Science Recent Developments/Updates
6.17 Suzhou Pharmaceutical Technology
6.17.1 Suzhou Pharmaceutical Technology Corporation Information
6.17.2 Suzhou Pharmaceutical Technology Tacrolimus Description and Business Overview
6.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
6.17.5 Suzhou Pharmaceutical Technology Recent Developments/Updates
6.18 Accura Pharmaceuticals
6.18.1 Accura Pharmaceuticals Corporation Information
6.18.2 Accura Pharmaceuticals Tacrolimus Description and Business Overview
6.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
6.18.5 Accura Pharmaceuticals Recent Developments/Updates
6.19 Fujisawa Pharmaceutical
6.19.1 Fujisawa Pharmaceutical Corporation Information
6.19.2 Fujisawa Pharmaceutical Tacrolimus Description and Business Overview
6.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
6.19.5 Fujisawa Pharmaceutical Recent Developments/Updates
6.20 Sichuan Med-Shine Pharmaceutical
6.20.1 Sichuan Med-Shine Pharmaceutical Corporation Information
6.20.2 Sichuan Med-Shine Pharmaceutical Tacrolimus Description and Business Overview
6.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
6.20.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.21 Sinopharm Chuankang Pharmaceutical
6.21.1 Sinopharm Chuankang Pharmaceutical Corporation Information
6.21.2 Sinopharm Chuankang Pharmaceutical Tacrolimus Description and Business Overview
6.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
6.21.5 Sinopharm Chuankang Pharmaceutical Recent Developments/Updates
6.22 Yamanouchi Pharmaceutical
6.22.1 Yamanouchi Pharmaceutical Corporation Information
6.22.2 Yamanouchi Pharmaceutical Tacrolimus Description and Business Overview
6.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
6.22.5 Yamanouchi Pharmaceutical Recent Developments/Updates
6.23 Zhongmei Huadong Pharmaceutical
6.23.1 Zhongmei Huadong Pharmaceutical Corporation Information
6.23.2 Zhongmei Huadong Pharmaceutical Tacrolimus Description and Business Overview
6.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
6.23.5 Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.24 Hisun Pharmaceutical
6.24.1 Hisun Pharmaceutical Corporation Information
6.24.2 Hisun Pharmaceutical Tacrolimus Description and Business Overview
6.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
6.24.5 Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tacrolimus Industry Chain Analysis
7.2 Tacrolimus Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tacrolimus Production Mode & Process
7.4 Tacrolimus Sales and Marketing
7.4.1 Tacrolimus Sales Channels
7.4.2 Tacrolimus Distributors
7.5 Tacrolimus Customers
8 Tacrolimus Market Dynamics
8.1 Tacrolimus Industry Trends
8.2 Tacrolimus Market Drivers
8.3 Tacrolimus Market Challenges
8.4 Tacrolimus Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 167
USD 3950.00
(Single User License)
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-22
Pages: 127
USD 4900.00
(Single User License)
The global market for Tacrolimus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 108
USD 2900.00
(Single User License)
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 151
USD 3950.00
(Single User License)
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 117
USD 4250.00
(Single User License)
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 147
USD 2900.00
(Single User License)
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 158
USD 3950.00
(Single User License)
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 167
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 127
The global market for Tacrolimus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 108
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 151
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 117
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 147
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 158
REPORT COVERAGE
Market Segmentation
Report Scope
Chapter Outline
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research